Accessibility Tools

Texas General Contracting
Texas General Contracting
Texas General Contracting
Texas General Contracting
Texas General Contracting
Texas General Contracting
Texas General Contracting
Texas General Contracting
retina-vitreous-of-texas-01.jpg
retina-vitreous-of-texas-02.jpg
retina-vitreous-of-texas-03.jpg
retina-vitreous-of-texas-04.jpg
retina-vitreous-of-texas-05.jpg
retina-vitreous-of-texas-06.jpg
retina-vitreous-of-texas-07.jpg
retina-vitreous-of-texas-08.jpg

Diabetic Retinopathy

Pavilion GR41675 – Genentech - Roche [Enrollment Closed]

A Phase III, Multicenter, Randomized study of the efficacy, safety, and pharmacokinetics of the Port Delivery System with Ranizumab in patients with Diabetic Retinopathy

Condor: CRTH258D2301 – Novartis [Enrollment Closed]

Novartis pharmaceuticals trail entitled: A 96-week, two-arm, randomized single-masked, multi-center, Phase III study assessing the efficacy and safety of Brolucizumab 6mg compared to Panretinal Photocoagulation Laser in patients with Proliferative Diabetic Retinopathy.

Epiretinal Membranes (Macular Puckers)
Complications of cataract, glaucoma and other ocular surgery
Retinal Vascular Occlusive Disease (retinal artery and retinal vein occlusions)
Ocular trauma
Myopic macular degeneration
Sickle cell retinopathy
Central serous retinopathy
Endophthalmitis (intraocular infections)
Retinitis and chorioretinitis
Uveitis
Hereditary retinal degenerations (i.e., retinitis pigmentosa and Stargardt’s disease)
Choroidal nevus and melanoma

No matter how common a clinical condition may be, we approach each patient with the highest level of individual attention, consideration, and evaluation. Our depth of experience and collective expertise allows us to personalize the treatment techniques appropriate for each individual.